Why ASML Stock Surged 9.5% to an All-Time High

Musk amplified the buzz himself over the weekend, posting on X that ASML is "arguably the greatest company in Europe" . The endorsement sent the stock up 5.8% on Monday, June 8 . But the real substance came on June 11. Musk addressed ASML employees virtually, laying out the scale of his ambition. Terafab is designed to produce 1 terawatt of annual chip output—roughly double current U.S. consumption . The estimated cost of the facility has ballooned to between $119 and $122 billion . For context, initial estimates in March 2026 pegged the investment at "at least $55 billion" .

For ASML, the implications are enormous. Terafab aims to produce chips at the 2-nanometer node and beyond, a task that is impossible without ASML's High-NA Extreme Ultraviolet (EUV) lithography machines . ASML is the sole global supplier of these tools, each of which carries a price tag of roughly $370–400 million . Securing a block of these machines on the timeline Terafab requires would represent one of the largest single orders in the company's history .

ASML's Own Bullish Guidance Added Fuel

While the Terafab narrative dominated headlines, ASML's own financial outlook provided a powerful fundamental tailwind. In the same early-June period, the company raised its 2026 revenue guidance to €36–€40 billion, explicitly citing AI-driven demand for its unique EUV lithography tools . The upgraded forecast reinforced the view that the company is not just a speculative beneficiary of futuristic projects, but is currently experiencing surging demand across its entire customer base, from TSMC to Samsung and Intel .

The guidance lift came on the heels of a remarkable first half of 2026. ASML shares were already up 64% year-to-date before this latest surge . Record quarterly orders reported in late January had set the stage, with bookings reaching €13.1 billion and smashing consensus estimates .

Oracle's Capex Paradox: Bad for Oracle, Good for the Sector

On the same day ASML was surging, Oracle reported its fiscal Q4 2026 results . At first glance, the numbers looked strong: adjusted EPS of $2.11 beat estimates of $1.95, and revenue of $19.2 billion edged past expectations of $19.1 billion . But Oracle's stock plunged roughly 8% .

The reason? The company announced plans to raise an additional $20 billion in equity and debt to fund its AI data center buildout . This aggressive financing plan spooked Oracle's own investors, who worried about dilution and balance-sheet strain. During the fiscal year, Oracle's capex had already hit $55.7 billion against just $32 billion in operating cash flow, pushing free cash flow deeply negative and swelling debt to $130 billion .

However, for the semiconductor equipment sector, this was a resoundingly bullish signal. Investors interpreted Oracle's insatiable need for data center capacity as fresh proof that the AI chip capex cycle is still intensifying, not peaking . The market saw Oracle's spending not as wasteful, but as a leading indicator of sustained, powerful demand for the advanced manufacturing tools that ASML and its peers produce .

A Broader Sector Rebound

The rally in ASML was part of a powerful wave that lifted the entire semiconductor equipment complex. The Philadelphia Semiconductor Index had staged a dramatic 6.5% rebound on June 8, recovering sharply from a rout in the prior week . TSMC's massive $52–$56 billion capex plan for 2026 had already set a bullish tone, and the collective view among investors was that chipmakers are locked into a multi-year spending boom .

On June 11, the market bought nearly everything tied to AI hardware: semiconductor capital equipment, memory, storage, networking, and even power and electrical infrastructure stocks rallied . Oracle was punished, but its spending was the sector's gain.

The Relative Value Argument

A subtle but powerful force also attracted buyers: ASML's valuation, despite its record run, looked relatively cheap compared to peers. With a 64% year-to-date gain, ASML had actually underperformed the broader U.S. semiconductor sector . Analysts described the stock as trading at its cheapest relative valuation in a decade . This disparity drew value-conscious investors who saw the monopoly-like grip on EUV technology as undervalued, especially against the backdrop of Terafab's potential to add a massive new customer.

Important Risks to Consider

The euphoric session did not eliminate legitimate concerns:

• Valuation stretch: GF Value, a proprietary fair-value estimate, pegged ASML's intrinsic value at approximately $1,100, implying the stock at $1,899.48 was trading at a 72% premium . The trailing P/E of 60.8x sits well above its five-year median of 39.07x .
• Terafab execution risk: For all its ambition, Terafab remains a project with an uncertain path to completion. Its own S-1 filings note that specific projects carry no guarantee of success . Mizuho analyst Jordan Klein described Terafab as a "potential call option" for wafer fab equipment upside, not yet a funded certainty .
• EUV shipping bottlenecks: Even if orders materialize, ASML's capacity to deliver its incredibly complex High-NA EUV machines on an accelerated timeline is far from guaranteed, with order books already under extreme pressure .
• Capex cycle sensitivity: The entire sector's fortunes are now tightly correlated. A slowdown in hyperscaler spending or a single major fab project delay could trigger a sharp correction across semiconductor equipment stocks .

The June 11 surge was a textbook convergence of narrative, fundamentals, and sector momentum. Terafab provided the vision, ASML's guidance gave it a near-term anchor, and Oracle's massive spending confirmed the trend is real. Whether that confluence can push the stock meaningfully higher from these levels will depend on orders translating from blueprints into purchase agreements.